1-4 of 4
Antonio Ribeiro
Close
Sort by
Journal Articles

Quantitative Multiplex Immunohistochemistry Identifies Immunosuppression in the AML Bone Marrow and NK-Cells As Prognostic Biomarker in Intermediate-Risk Patients

Oscar Brück, MD, Olli Dufva, Sami Blom, MSc, Riku Turkki, MSc, Mette Ilander, PhD, Sanna M. Siitonen, MD PhD, Panu Kovanen, MD PhD, Celine Pallaud, PhD, Pedro Marques Ramos, PhD, Hanna Lähteenmäki, Katja Välimäki, Antonio Ribeiro, BSc, Olli Kallioniemi, MD PhD, Kimmo Porkka, MD PhD, Teijo Pellinen, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2774.
https://doi.org/10.1182/blood-2018-99-116628
Published: 2018
Journal Articles

High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia

Helena Hohtari, MD, Oscar Brück, Sami Blom, MSc, Riku Turkki, MSc, Antonio Ribeiro, BSc, Marjatta Sinisalo, MD PhD, Panu Kovanen, MD PhD, Olli Kallioniemi, MD PhD, Teijo Pellinen, PhD, Kimmo Porkka, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3985.
https://doi.org/10.1182/blood.V130.Suppl_1.3985.3985
Published: 2017
Journal Articles

Extensive Immunosuppression in the Acute Myeloid Leukemia (AML) Bone Marrow and Discovery of NK Cells As Biomarker of Superior Survival

Oscar Brück, Sami Blom, MSc, Olli Dufva, BSc, Riku Turkki, MSc, Antonio Ribeiro, BSc, Sanna Siitonen, MD PhD, Panu Kovanen, MD PhD, Olli Kallioniemi, MD PhD, Kimmo Porkka, MD PhD, Teijo Pellinen, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3943.
https://doi.org/10.1182/blood.V130.Suppl_1.3943.3943
Published: 2017
Journal Articles

Immune Cell Profiling in CML Bone Marrow By Multiplex Immunohistochemistry

Brück Oscar, MD, Sami Blom, MSc, Riku Turkki, MSc, Panu E Kovanen, MD PhD, Antonio Ribeiro, Nina Linder, MD PhD, Johan Lundin, MD PhD, Olli Kallioniemi, MD PhD, Teijo Pellinen, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1897.
https://doi.org/10.1182/blood.V128.22.1897.1897
Published: 2016